Valuation: Boston Scientific Corporation

Market Cap 65.44B 57.36B 53.02B 48.77B 92.01B 6,311B 93.49B 634B 249B 3,088B 246B 240B 10,638B P/E 2026 *
16.2x
P/E 2027 * 15.4x
Enterprise Value 72B 63.11B 58.34B 53.65B 101B 6,943B 103B 698B 273B 3,397B 270B 264B 11,705B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 2.95x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week-0.99%
Current month+3.58%
1 month-0.27%
3 months-27.51%
6 months-51.52%
Current year-53.63%
1 week 42.2
Extreme 42.2
45.45
1 month 42.2
Extreme 42.2
46.37
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
28/05/26 Don

Chief Executive Officer

-386,755 0.0261%
20/05/26 Buy

Director

2,250 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-0.99%-57.40%-17.30% 65.44B
-0.98%-0.20%+30.26%-2.01% 198B
-1.06%+1.06%+7.56%-17.22% 144B
+2.11%-13.29%-31.61%+1.54% 122B
-0.12%-6.71%+11.85%-7.58% 49.36B
+0.65%-0.59%-22.82%-31.15% 44.74B
+0.34%-1.42%+17.94%+6.09% 37.13B
-2.44%-3.38%+28.03%+28.90% 36.23B
-1.00%-0.83%-24.59%-10.23% 28.7B
-0.02%-3.12%-14.68%-22.69% 28.69B
Average -0.25%-2.78%-5.55%-7.17% 75.48B
Weighted average by Cap. -0.22%-2.61%-0.56%-6.98%

Financials

2026 *2027 *
Net sales 21.57B 18.91B 17.48B 16.08B 30.33B 2,080B 30.82B 209B 81.93B 1,018B 81.01B 79.24B 3,507B 23.32B 20.44B 18.9B 17.38B 32.79B 2,249B 33.32B 226B 88.57B 1,100B 87.58B 85.67B 3,791B
Net income 3.87B 3.39B 3.14B 2.89B 5.45B 373B 5.53B 37.52B 14.71B 183B 14.54B 14.23B 630B 4.11B 3.6B 3.33B 3.06B 5.78B 396B 5.87B 39.83B 15.61B 194B 15.44B 15.1B 668B
Net Debt 6.56B 5.75B 5.31B 4.89B 9.22B 632B 9.37B 63.53B 24.91B 309B 24.63B 24.09B 1,066B 3.43B 3B 2.78B 2.55B 4.82B 330B 4.89B 33.19B 13.01B 162B 12.86B 12.58B 557B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
20/07/26 $44.21 +0.40% 4,867,201
17/07/26 $44.03 -1.32% 15,522,226
16/07/26 $44.62 +3.67% 18,783,113
15/07/26 $43.04 +0.96% 14,531,545
14/07/26 $42.63 -4.52% 20,088,275
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
44.03USD
Average target price
72.43USD
Spread / Average Target
+64.50%

Quarterly revenue - Rate of surprise